-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
Sangamo Therapeutics, Inc quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2010 to 2023.
- Sangamo Therapeutics, Inc Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2024 was -$36.1M, a 68.4% increase year-over-year.
- Sangamo Therapeutics, Inc Net Income (Loss) Attributable to Parent for the twelve months ending June 30, 2024 was -$250M, a 25.8% decline year-over-year.
- Sangamo Therapeutics, Inc annual Net Income (Loss) Attributable to Parent for 2023 was -$258M, a 34.1% decline from 2022.
- Sangamo Therapeutics, Inc annual Net Income (Loss) Attributable to Parent for 2022 was -$192M, a 7.85% decline from 2021.
- Sangamo Therapeutics, Inc annual Net Income (Loss) Attributable to Parent for 2021 was -$178M, a 47.3% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)